You are here

  • Home
  • Archive
  • Volume 20, Issue 3
  • Invasive revascularisation in patients with moderate intermittent claudication provides a significant improvement in quality of life compared with conservative treatment

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Invasive revascularisation in patients with moderate intermittent claudication provides a significant improvement in quality of life compared with conservative treatment
  1. Andrew K Kurklinsky
  1. Correspondence to : Dr Andrew K Kurklinsky, Division of Cardiovascular Medicine, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA; kurklinsky.andrew{at}mayo.edu

https://doi.org/10.1136/ebmed-2015-110176

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Nordanstig J, Taft C, Hensäter M, et al. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation 2014;130:939–47OpenUrlAbstract/FREE Full Text.

    Context

    In cases of severe intermittent claudication (IC), successful revascularisation provides significant symptomatic improvement. In cases of mild IC, revascularisation has exceedingly high risks. The choice between invasive revascularisation and non-invasive treatments for moderate severity IC is often difficult. Treatment benefits may be relative in terms of the effects on quality of life (QoL).

    Methods

    This trial randomised consecutive patients with moderate IC into two equal groups to compare the effects of revascularisation and non-invasive treatment on health-related QoL assessed by the Medical Outcomes Study Short Form 36 (SF-36) and Vascular Quality of Life Questionnaire (VascuQoL). Self-reported maximum walking distance (MWD) and IC distance (ICD) on a …

    View Full Text

    Footnotes

    • Twitter Follow Andrew Kurklinsky at @kurklinsky

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.